Summit Therapeutics (SMMT) Capital Expenditures Growth (3y) (2022 - 2026)
Summit Therapeutics (SMMT) Capital Expenditures Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - | - |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -12.25% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.14 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.46 Bn | 37.46 Bn | - | - |
| 10 | Summit Therapeutics | 10.48 Bn | 9.79 Bn | - | 121.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 121.38% |
| Mar 31, 2026 | 168.51% |
| Dec 31, 2025 | -628.80% |
| Sep 30, 2025 | 255.16% |
| Jun 30, 2025 | 97.38% |
| Mar 31, 2025 | 57.82% |
| Dec 31, 2024 | 178.60% |
| Sep 30, 2024 | -51.83% |
| Jun 30, 2024 | -70.19% |
| Mar 31, 2024 | -301.49% |
| Dec 31, 2023 | -65.80% |
| Sep 30, 2023 | -37.00% |
| Jun 30, 2023 | -46.28% |
| Mar 31, 2023 | 20.89% |
| Dec 31, 2022 | -27.54% |
| Mar 31, 2022 | 63.02% |